Abstract:Background: Sequencing analysis of circulating tumor cells (CTCs) enables "liquid biopsy" to guide precision oncology strategies. However, this requires low-template whole genome amplification (WGA) that is prone to errors and biases from uneven amplifications. Currently, quality control (QC) methods for WGA products, as well as the number of CTCs needed for reliable downstream sequencing, remain poorly defined. We sought to define strategies for selecting and generating optimal WGA products from low-template input as it relates to their potential applications in precision oncology strategies. Methods: Single pancreatic cancer cells (HPAF-II) were isolated using laser microdissection. WGA was performed using multiple displacement amplification (MDA), multiple annealing and looping based amplification (MALBAC) and PicoPLEX. Quality of amplified DNA products were assessed using a multiplex/RT-qPCR based method that evaluates for 8-cancer related genes and QC-scores were assigned. We utilized this scoring system to assess the impact of de novo modifications to the WGA protocol. WGA products were subjected to Sanger sequencing, array comparative genomic hybridization (aCGH) and next generation sequencing (NGS) to evaluate their performances in respective downstream analyses providing validation of the QC-score. Results: Single-cell WGA products exhibited a significant sample-to-sample variability in amplified DNA quality as assessed by our 8-gene QC assay. Single-cell WGA products that passed the pre-analysis QC had lower amplification bias and improved aCGH/NGS performance metrics when compared to single-cell WGA products that failed the QC. Increasing the number of cellular input resulted in improved QC-scores overall, but a resultant WGA product that consistently passed the QC step required a starting cellular input of at least 20-cells. Our modified-WGA protocol effectively reduced this number, achieving reproducible high-quality WGA products from ≥5-cells as a starting template. A starting cellular input of 5 to 10-cells amplified using the modified-WGA achieved aCGH and NGS results that closely matched that of unamplified, batch genomic DNA. Conclusion: The modified-WGA protocol coupled with the 8-gene QC serve as an effective strategy to enhance the quality of low-template WGA reactions. Furthermore, a threshold number of 5-10 cells are likely needed for a reliable WGA reaction and product with high fidelity to the original starting template.

Large fragment Bst DNA polymerase for whole genome amplification of DNA from formalin-fixed paraffin-embedded tissues

Whole-genome amplification: relative efficiencies of the current methods.

Recent Advances and Application of Whole Genome Amplification in Molecular Diagnosis and Medicine

DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly

MDA in Capillary for Whole Genome Amplification

Deep targeted sequencing of cytological tumor cells using whole genome amplification

Improved Protocol for Extracting Genomic DNA from Frozen Formalin-Fixed Tissue Resulting in High-Quality Whole Mtdna.

Improved Method Of Dna Reusing Based On The Multiple Displacement Amplification And Streptavidin Modified Magnetic Beads Immobilization Technology

Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utility

Evaluation of a whole genome amplification method based on improved ligation-mediated PCR

Effect of Phi29 Polymerase-Based Multiple Strand Displacement Whole Genome Amplification on the Proportion in DNA Mixtures

1D-Reactor Decentralized MDA for Uniform and Accurate Whole Genome Amplification.

Comparative study of whole genome amplification and next generation sequencing performance of single cancer cells

Use of FFPE-derived DNA in next generation sequencing: DNA extraction methods

Single nucleus DNA sequencing of flow sorted archived frozen and formalin fixed paraffin embedded solid tumors

Identification Of High-Confidence Somatic Mutations In Whole Genome Sequence Of Formalin-Fixed Breast Cancer Specimens

Dna Extraction from Formalin-Fixed and Paraffin-Embedded Tissues by Triton X-100 for Effective Amplification of Egfr Gene by Polymerase Chain Reaction

Protocol Development for Yielding High Quality DNA and RNA from Archived Formalin-Fixed Paraffin Embedded Tissues

DNA extraction from paraffin-embedded lung cancer tissue and PCR

Genome Coverage and Sequence Fidelity of Phi 29 Polymerase-Based Multiple Strand Displacement Whole Genome Amplification

Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications